NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade

NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade

New York, Jan 10, 2026, 06:16 ET — Market closed

  • NuScale Power shares rose 4.3% on Friday after a Bank of America upgrade.
  • Nuclear-linked names drew bids after Meta unveiled long-term nuclear supply and development deals.
  • Traders are eyeing whether SMR holds above $20 ahead of the next earnings update expected in early March.

NuScale Power Corporation shares ended Friday up 4.3% at $20.51, with U.S. markets shut for the weekend and trading set to resume on Monday.

The move mattered because the nuclear trade has snapped back on fresh demand signals from Big Tech, which is hunting stable power for data centers. Meta said it struck 20-year nuclear power agreements and would back development of small modular reactors, or SMRs — smaller reactor designs that aim to shift more construction into factories. Meta executive Joel Kaplan called the plans “one of the most significant corporate purchasers of nuclear energy in American history.” 1

NuScale, which develops SMR technology, has been a momentum name and a bruised one, and Friday’s bounce put it back on screens. BofA Securities upgraded the stock to “neutral” from “underperform” while cutting its price target to $28, citing a sharp pullback from earlier highs even as it flagged near-term cash needs and dilution risk tied to the company’s ENTRA1 partnership structure, Investing.com reported. 2

The broader sector helped. Several nuclear-related stocks rose after Meta’s announcements, including companies tied more directly to near-term supply and SMR development. 3

On the chart, NuScale’s Friday close is still below its 50-day moving average around $22.83 and far under the 200-day near $30.56 — levels many short-term traders use as signposts for trend and resistance. 4

One risk is financing. NuScale disclosed an at-the-market offering program allowing up to $750 million of shares to be sold into the market — a structure that can provide flexibility but can also weigh on the stock if investors expect heavier issuance. 5

The stock remains volatile: Nasdaq data show a 52-week range of $11.08 to $57.42, leaving plenty of air on either side if the sector trade turns or extends. 6

Next up, investors will watch for follow-through in nuclear-linked names when trading reopens, and for NuScale’s next earnings update, which is expected around March 2. 7

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Mastercard stock in focus for Monday after Trump floats 10% credit-card rate cap
Previous Story

Mastercard stock in focus for Monday after Trump floats 10% credit-card rate cap

Oracle stock jumps toward $200 as Stargate funding and a busy macro week collide
Next Story

Oracle stock jumps toward $200 as Stargate funding and a busy macro week collide

Go toTop